Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Orietta Dal Canton"'
Autor:
Paola Vanella, Orietta Dal Canton, Cinzia Ortega, Alessandra Gennari, Alfredo Berruti, Cosimo Sacco, Susanne Baier, Andrea R. Bellissimo, Elena Fea, Veronica Prati, Alessandro Comandone, Zuzana Sirotova, Consuelo Buttigliero, Francesca Valcamonico, Susanna Bianchi, Alberto Dalla Volta, Isabella Chiappino, Domenico Amoroso, Manuel Zamparini, Alessandra Mosca, Cristina Masini, Francesco Montagnani, Giovannino Ciccone, Marcello Tucci
Publikováno v:
European Journal of Cancer. 155:127-135
Background This study was designed to demonstrate the non-inferiority (NI) in overall survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and intermittent versus continuous docetaxel administration in metastatic castr
Autor:
Orietta Dal Canton, P. Bergnolo, C. Oliva, Simona Chiadò Cutin, P. Pochettino, F. Garetto, Antonella Boglione, Manuela Inguì, Alessandro Comandone, Lavinia Bianco
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 136:411-417
This phase II study was designed in order to evaluate efficacy and safety of the combination of vinorelbine (VNB), fluorouracil (FU) and leucovorin (LV) in patients with metastatic breast carcinoma (MBC) previously treated with anthracyclines and tax
Autor:
Davide Ottaviani, Alessandro Comandone, Antonella Boglione, P. Bergnolo, Raimondo Piana, Elena Giubellino, Veronica Prati, F. Garetto, P. Pochettino, Simona Chiadò Cutin, Orietta Dal Canton
Publikováno v:
Journal of Clinical Oncology. 35:e22528-e22528
e22528 Background: Elderly people represent more than 50% of STS patients, but few data are available in this population and old patients in clinical studies are underrepresented or not included. Aim of this retrospective, monoinstitutional study is
Autor:
Cristiano, Oliva, Paolo, Pochettino, Paola, Bergnolo, Antonella, Boglione, Simona Chiadò, Cutin, Manuela, Inguì, Orietta, Dal Canton, Ferdinando, Garetto, Manuela, Biscardi, Elisa, Berno, Alessandro, Comandone
Publikováno v:
Anticancer research. 28(4C)
Irinotecan (IRI) is a topoisomerase I inhibitor active as first- or second-line chemotherapy in advanced colorectal cancer (ACRC). Its combination with fluorouracil (FU) increases the response rate and prolongs survival. In order to identify a new ef
Autor:
Alessandro Comandone, Antonella Boglione, Simona Chiadò Cutin, P. Bergnolo, Davide Ottaviani, F. Garetto, C. Oliva, P. Pochettino, Orietta Dal Canton, Maria Vietti
Publikováno v:
Journal of Clinical Oncology. 33:e20646-e20646
e20646 Background: Nausea and fatigue are common side-effects of cancer chemotherapy (CT). Management of fatigue includes pharmacological treatments, psycho-educational and exercise programs. Exerc...
Autor:
P. Pochettino, F. Garetto, Simona Chiadò Cutin, Elena Giubellino, Davide Ottaviani, Maria Luisa Sartori, Orietta Dal Canton, P. Bergnolo, C. Oliva, Alessandro Comandone, Antonella Boglione
Publikováno v:
Journal of Clinical Oncology. 32:e11547-e11547
e11547 Background: Fulvestrant (F) is a pure antiestrogen drug approved for MBC of postmenopausal women with estrogen receptor positive disease. The CONFIRM trial has recently demonstrated that a double dose (500 mg/monthly) of F is superior to 250 m
Autor:
Alessandro Comandone, Antonella Boglione, William Liboni, Simona Chiadò Cutin, Orietta Dal Canton, Piero Picci, Piero Pignatta, C. Oliva, P. Bergnolo
Publikováno v:
Scopus-Elsevier
We report the first case of recurrent ifosfamide-related neurotoxicity in the same patient following two distinct administrations of the drug at different doses and schedules and with a long interval between the two episodes. Remarkably, the first ev
Autor:
F. Garetto, Alessandra Linari, Simona Chiadò Cutin, M. Turbiglio, Antonella Boglione, Orietta Dal Canton, Alessandro Comandone, Raimondo Piana, Elena Giubellino, P. Pazienza, G. Gino, P. Pochettino, P. Bergnolo, C. Oliva, Davide Ottaviani, Elena Maria Brach Del Prever
Publikováno v:
Journal of Clinical Oncology. 31:10572-10572
10572 Background: In STS third line treatment is poorly defined. However many patients (pts), after aggressive therapy as first and second line progress in their disease ask to be treated. Oral cyclophosphamide (CPM) was already used in breast cancer
Autor:
Alessandro Comandone, C. Oliva, Alessandra Linari, Gabriella Monasterolo, M. Turbiglio, Elena Giubellino, Elena Maria Brach Del Prever, G. Gino, Antonella Boglione, Raimondo Piana, P. Pochettino, Simona Chiadò Cutin, P. Bergnolo, Orietta Dal Canton, C. Faletti, Elisa Berno, Manuela Inguì
Publikováno v:
Journal of Clinical Oncology. 30:10055-10055
10055 Background: STS are 1% of malignant tumors in adults. Rarity, heterogeneity in presentation, low expertise in primary care physicians (PCP) or in general hospitals, organisation problems in specialized centers may cause a delay in both diagnosi